Jci_page_head_homepage_01 Jci_page_head_homepage_02
Joshua VanHouten, Pamela Dann, Grace McGeoch, Edward M. Brown, Karen Krapcho, Margaret Neville, John J. Wysolmerski
Published in Volume 113, Issue 4
J Clin Invest. 2004; 113(4):598–608 doi:10.1172/JCI18776
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 1

CaR expression over the course of mammary gland development. (a) RNase protection analysis of CaR mRNA levels during mouse mammary gland development. Fifty micrograms of total RNA prepared from mouse mammary glands harvested at the timepoints noted in the figure was assayed. Five micrograms of mouse kidney RNA served as a positive control. Fifty micrograms of yeast RNA served as a negative control. (b) Profile of CaR transcript representation in an Affymetrix gene expression database. Each point represents the mean of four separate RNA samples prepared from mammary glands harvested at the indicated times. Error bars represent the SEM. P7, P12, and P17 represent days 7, 12, and 17 of pregnancy, respectively; L1, L2, and L9 represent days 1, 2, and 9 of lactation, respectively; I2 represents the second day of involution after weaning. The profile for GAPDH transcripts is provided for comparison.